ERBB2 and breast cancer: Our primary aim in this study was, therefore, to investigate the comparative prognostic performance of image analysis-based, quantitative, measures of ER, PR, HER2, and KI67, combined in the IHC4-score, vs. categorical combinations of these markers in luminal (A-like/B-like) breast cancer subtype.